The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs — knowledge graph · CancerIndex

Knowledge graph · Trial

The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs

RECRUITING

Identifier: CI-TRIAL-00078796
Entity page: /trial/NCT05159245 ↗
Edges: 17

Neighbours: 3 cancers14 drugs
Drawn: 17 of 17 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs condition of …CONDITION_OFderived3 of 3
← condition of	Hematopoietic and Lymphoid Cell Neoplasm registry condition “Haematological Malignancy” mapped PROBABILISTIC	—	—	Hematopoietic and Lymphoid Cell Neoplasm	1	Observed	clinicaltrials	graph →
← condition of	Malignant Neoplasm registry condition “Advanced Cancer” mapped CURATED_BROADER

The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs intervention of …INTERVENTION_OFderived14 of 14
← intervention of	Abemaciclibsmall molecule registry intervention “Abemaciclib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Alectinibsmall molecule registry intervention “Alectinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Apalutamidesmall molecule registry intervention “Apalutamide” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Atezolizumabmonoclonal antibody registry intervention “Atezolizumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Cobimetinibsmall molecule registry intervention “Cobimetinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Dabrafenibsmall molecule registry intervention “Dabrafenib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Dabrafenib/Trametinib Regimen registry intervention “Dabrafenib+Trametinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Entrectinibsmall molecule registry intervention “Entrectinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Pemigatinibsmall molecule registry intervention “Pemigatinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Regorafenibsmall molecule registry intervention “Regorafenib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Tepotinibsmall molecule registry intervention “Tepotinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Trametinibsmall molecule registry intervention “Trametinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Vemurafenibsmall molecule registry intervention “Vemurafenib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Vismodegibsmall molecule registry intervention “Vismodegib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Paths